CD44 and breast cancer: Interestingly, CDK4 may act as a stem cell regulator by modulating the expression of CD44 and CD24 in BC cells as the CDK4 inhibitor Palbociclib decreased the fraction of CD44+/CD24− stem cells in MDA-MB-231 cells [61].